In just three years, Farmington-based medical device company CytoVeris has gone from a small startup with the goal of helping surgeons better detect cancer, to a company that’s raised $8 million and hired 19 employees, with plans to add six more in the year ahead.
Furthermore, its cancer detection device has made strides; a feasibility study is scheduled to take place in the spring, while clinical trials could start in early 2023, company officials have said.